Xuan Marian Thai

Array ( [id] => 6412651 [patent_doc_number] => 20100166764 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'ANTI-MYOSTATIN ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/376390 [patent_app_country] => US [patent_app_date] => 2007-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11860 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20100166764.pdf [firstpage_image] =>[orig_patent_app_number] => 12376390 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6348831 [patent_doc_number] => 20100021487 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'VACCINES AND METHODS FOR CONTROLLING ADIPOSITY' [patent_app_type] => utility [patent_app_number] => 12/374908 [patent_app_country] => US [patent_app_date] => 2007-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7035 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20100021487.pdf [firstpage_image] =>[orig_patent_app_number] => 12374908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4964821 [patent_doc_number] => 20080107641 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'METHOD OF TREATING STROKE WITH THROMBOLYTIC AGENT' [patent_app_type] => utility [patent_app_number] => 11/832291 [patent_app_country] => US [patent_app_date] => 2007-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10566 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20080107641.pdf [firstpage_image] =>[orig_patent_app_number] => 11832291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4669364 [patent_doc_number] => 20080044424 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'ANTAGONISTS OF PROTEASE ACTIVATED RECEPTOR-1 (PAR1)' [patent_app_type] => utility [patent_app_number] => 11/778924 [patent_app_country] => US [patent_app_date] => 2007-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19044 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20080044424.pdf [firstpage_image] =>[orig_patent_app_number] => 11778924 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6616858 [patent_doc_number] => 20100003266 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'TARGETED IMMUNE CONJUGATES' [patent_app_type] => utility [patent_app_number] => 12/306457 [patent_app_country] => US [patent_app_date] => 2007-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 19284 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20100003266.pdf [firstpage_image] =>[orig_patent_app_number] => 12306457 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5198727 [patent_doc_number] => 20070298045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-27 [patent_title] => 'Method and vaccine for non-genetically engineered atavism growth enhancement' [patent_app_type] => utility [patent_app_number] => 11/812274 [patent_app_country] => US [patent_app_date] => 2007-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 1406 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20070298045.pdf [firstpage_image] =>[orig_patent_app_number] => 11812274 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4751964 [patent_doc_number] => 20080160037 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'NOVEL BETA-DEFENSINS' [patent_app_type] => utility [patent_app_number] => 11/764048 [patent_app_country] => US [patent_app_date] => 2007-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 22278 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20080160037.pdf [firstpage_image] =>[orig_patent_app_number] => 11764048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4710602 [patent_doc_number] => 20080299128 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-04 [patent_title] => 'Effect of Bst2 on inflammation' [patent_app_type] => utility [patent_app_number] => 11/757329 [patent_app_country] => US [patent_app_date] => 2007-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 44106 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20080299128.pdf [firstpage_image] =>[orig_patent_app_number] => 11757329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 173999 [patent_doc_number] => 07659378 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-09 [patent_title] => 'Hepatocyte growth factor (HGF) binding antibody' [patent_app_type] => utility [patent_app_number] => 11/757094 [patent_app_country] => US [patent_app_date] => 2007-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 34245 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/659/07659378.pdf [firstpage_image] =>[orig_patent_app_number] => 11757094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4965745 [patent_doc_number] => 20080108565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'HEPATOCYTE GROWTH FACTOR (HGF) BINDING PROTEINS' [patent_app_type] => utility [patent_app_number] => 11/757059 [patent_app_country] => US [patent_app_date] => 2007-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 34395 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20080108565.pdf [firstpage_image] =>[orig_patent_app_number] => 11757059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10837972 [patent_doc_number] => 08865645 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-21 [patent_title] => 'Method of treating lung fibrosis using ST2 polypeptide' [patent_app_type] => utility [patent_app_number] => 12/301736 [patent_app_country] => US [patent_app_date] => 2007-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 16 [patent_no_of_words] => 26216 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12301736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5297057 [patent_doc_number] => 20090011983 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => '186 Human Secreted Proteins' [patent_app_type] => utility [patent_app_number] => 11/745580 [patent_app_country] => US [patent_app_date] => 2007-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 231695 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0011/20090011983.pdf [firstpage_image] =>[orig_patent_app_number] => 11745580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5230320 [patent_doc_number] => 20070292427 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-20 [patent_title] => 'Substantially pure steroidogenesis inducing peptide and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/799994 [patent_app_country] => US [patent_app_date] => 2007-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 20615 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20070292427.pdf [firstpage_image] =>[orig_patent_app_number] => 11799994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4687731 [patent_doc_number] => 20080031912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-07 [patent_title] => 'METHOD FOR CONTROLLING CELL MIGRATION ON A SURFACE' [patent_app_type] => utility [patent_app_number] => 11/744171 [patent_app_country] => US [patent_app_date] => 2007-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6368 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20080031912.pdf [firstpage_image] =>[orig_patent_app_number] => 11744171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4898898 [patent_doc_number] => 20080118512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-22 [patent_title] => 'Antibodies binding to the extracellular domain of the receptor tyrosine kinase ALK' [patent_app_type] => utility [patent_app_number] => 11/796549 [patent_app_country] => US [patent_app_date] => 2007-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13452 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20080118512.pdf [firstpage_image] =>[orig_patent_app_number] => 11796549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5224685 [patent_doc_number] => 20070253951 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-01 [patent_title] => 'Humanized c-Kit antibody' [patent_app_type] => utility [patent_app_number] => 11/789665 [patent_app_country] => US [patent_app_date] => 2007-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 19963 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20070253951.pdf [firstpage_image] =>[orig_patent_app_number] => 11789665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8421320 [patent_doc_number] => 08277809 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-02 [patent_title] => 'CXCL13 antagonists and their use for the treatment of inflammatory diseases' [patent_app_type] => utility [patent_app_number] => 11/738019 [patent_app_country] => US [patent_app_date] => 2007-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 22521 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11738019 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7523188 [patent_doc_number] => 08026344 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-27 [patent_title] => 'Targeted binding agents directed to uPAR and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/733157 [patent_app_country] => US [patent_app_date] => 2007-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 17 [patent_no_of_words] => 47532 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/026/08026344.pdf [firstpage_image] =>[orig_patent_app_number] => 11733157 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5409578 [patent_doc_number] => 20090123476 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => 'TARGETED BINDING AGENTS DIRECTED TO UPAR AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/296593 [patent_app_country] => US [patent_app_date] => 2007-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 47329 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20090123476.pdf [firstpage_image] =>[orig_patent_app_number] => 12296593 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 584151 [patent_doc_number] => 07449553 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-11 [patent_title] => 'Antibody that binds ceramidase' [patent_app_type] => utility [patent_app_number] => 11/783246 [patent_app_country] => US [patent_app_date] => 2007-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14214 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/449/07449553.pdf [firstpage_image] =>[orig_patent_app_number] => 11783246 [rel_patent_id] =>[rel_patent_doc_number] =>)